Oxford BioDynamics appoints Professor to its scientific advisory board

 1 min | By Gill Oliver
 |  | Oct 31st 2019

Oxford BioDynamics has announced Professor Iain McInnes will join its scientific advisory board.

Professor McInnes is director of the Institute of Infection, Immunity and Inflammation at Glasgow University and internationally recognised for his research into arthritis.

He will use his expertise to help further develop OBD’S EpiSwitch technology, which analyses biomarkers to help pharma and biotech companies identify how patients will react to specific drugs.

go deeper

Oxford BioDynamics, which has its head office in Beaumont Street and labs at Oxford Business Park, was spun-out of Oxford University in 2007.

It floated on AIM in 2016 and received the Queen’s Award for Innovation in April this year.

Professor McInnes, who was awarded a CBE for services to medicine last December, has collaborated with Oxford BioDynamics on research projects during the past five years.

OBD chief executive Christian Hoyer Millar said: “Iain is an eminent professor and an expert in inflammatory disease processes, a core focus for us.

“His knowledge and experience will be hugely beneficial, as we further collaborate with leading pharma, biotech and research institutions.”

Professor McInnes added: “I have known OBD for many years now and am extremely impressed with the predictive power of EpiSwitch to identify patients with rheumatoid arthritis who would not respond adequately to methotrexate, the anchor drug used in this disease.”

About the Author

Gill Oliver

Gill Oliver is a professionally trained journalist who’s written for The New Statesman, The Bureau for Investigative Journalism, The Daily Mail’s business section This is Money, The Press Association, The Huffington Post plus a host of national magazines, news agencies and trade and industry journals. She’s also spent nine years reporting on the Oxfordshire business and tech scene for The Oxford Times and The Oxford Mail.

Subscribe to our newsletter